CapsoVision, Inc. ( (CV) ) has released its Q3 earnings. Here is a breakdown of the information CapsoVision, Inc. presented to its investors.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
CapsoVision, Inc. is a commercial-stage medical technology company specializing in advanced imaging and AI-enabled capsule endoscopy solutions, primarily serving the gastrointestinal diagnostics sector with innovative products like the CapsoCam Plus®.
In its third-quarter 2025 earnings report, CapsoVision, Inc. announced a 19% revenue increase compared to the same period in 2024, alongside strategic advancements in product development and partnerships aimed at enhancing its diagnostic capabilities.
Key financial highlights include a revenue of $3.5 million, driven by increased sales of the CapsoCam Plus capsules, and a gross profit of $1.9 million. The company also reported significant growth in new accounts by 31% and completed an initial public offering in July 2025, raising net proceeds of $23.4 million. Strategically, CapsoVision has submitted an FDA application for Breakthrough Device Designation for early-stage pancreatic cancer detection and entered a development agreement with Canon Inc. for advanced imaging technology.
Despite a net loss of $7.9 million for the quarter, CapsoVision is focused on expanding its product pipeline, including the development of a new generation colon-capsule and enhanced AI analytics. The appointment of David Garcia as Senior Vice President of Finance is expected to strengthen the company’s financial leadership.
Looking ahead, CapsoVision remains committed to advancing its gastrointestinal screening and diagnostics solutions, with plans to continue its regulatory submissions and product development efforts, positioning itself for future growth in the medical technology industry.